Literature DB >> 23326162

Performance of liver stiffness measurements by transient elastography in chronic hepatitis.

Giovanna Ferraioli1, Carmine Tinelli, Barbara Dal Bello, Mabel Zicchetti, Raffaella Lissandrin, Gaetano Filice, Carlo Filice, Elisabetta Above, Giorgio Barbarini, Enrico Brunetti, Willy Calderon, Marta Di Gregorio, Roberto Gulminetti, Paolo Lanzarini, Serena Ludovisi, Laura Maiocchi, Antonello Malfitano, Giuseppe Michelone, Lorenzo Minoli, Mario Mondelli, Stefano Novati, Savino F A Patruno, Alessandro Perretti, Gianluigi Poma, Paolo Sacchi, Domenico Zanaboni, Marco Zaramella.   

Abstract

AIM: To compare results of liver stiffness measurements by transient elastography (TE) obtained in our patients population with that used in a recently published meta-analysis.
METHODS: This was a single center cross-sectional study. Consecutive patients with chronic viral hepatitis scheduled for liver biopsy at the outpatient ward of our Infectious Diseases Department were enrolled. TE was carried out by using FibroScan™ (Echosens, Paris, France). Liver biopsy was performed on the same day as TE, as day case procedure. Fibrosis was staged according to the Metavir scoring system. The diagnostic performance of TE was assessed by using receiver operating characteristic (ROC) curves and the area under the ROC curve analysis.
RESULTS: Two hundred and fifty-two patients met the inclusion criteria. Six (2%) patients were excluded due to unreliable TE measurements. Thus, 246 (171 men and 75 women) patients were analyzed. One hundred and ninety-five (79.3%) patients had chronic hepatitis C, 41 (16.7%) had chronic hepatitis B, and 10 (4.0%) were coinfected with human immunodeficiency virus. ROC curve analysis identified optimal cut-off value of TE as high as 6.9 kPa for F ≥ 2; 7.9 kPa for F ≥ 3; 9.6 kPa for F = 4 in all patients (n = 246), and as high as 6.9 kPa for F ≥ 2; 7.3 kPa for F ≥ 3; 9.3 kPa for F = 4 in patients with hepatitis C (n = 195). Cut-off values of TE obtained by maximizing only the specificity were as high as 6.9 kPa for F ≥ 2; 9.6 kPa for F ≥ 3; 12.2 kPa for F = 4 in all patients (n = 246), and as high as 7.0 kPa for F ≥ 2; 9.3 kPa for F ≥ 3; 12.3 kPa for F = 4 in patients with hepatitis C (n = 195).
CONCLUSION: The cut-off values of TE obtained in this single center study are comparable to that obtained in a recently published meta-analysis that included up to 40 studies.

Entities:  

Keywords:  Chronic viral hepatitis; Elastography; FibroScan; Hepatitis C; Liver; Liver biopsy; Liver fibrosis; Transient elastography; Ultrasound

Mesh:

Year:  2013        PMID: 23326162      PMCID: PMC3542745          DOI: 10.3748/wjg.v19.i1.49

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

1.  Pain experienced during percutaneous liver biopsy.

Authors:  L Castéra; I Nègre; K Samii; C Buffet
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 2.  Liver biopsy.

Authors:  A A Bravo; S G Sheth; S Chopra
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 3.  Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435].

Authors:  Valeer J Desmet
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

4.  An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group.

Authors:  P Bedossa; T Poynard
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

5.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Authors:  Arie Regev; Mariana Berho; Lennox J Jeffers; Clara Milikowski; Enrique G Molina; Nikolaos T Pyrsopoulos; Zheng-Zhou Feng; K Rajender Reddy; Eugene R Schiff
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

6.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

7.  Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.

Authors:  L Rizzo; Vincenza Calvaruso; B Cacopardo; N Alessi; M Attanasio; S Petta; F Fatuzzo; A Montineri; A Mazzola; L L'abbate; G Nunnari; F Bronte; V Di Marco; A Craxì; C Cammà
Journal:  Am J Gastroenterol       Date:  2011-10-04       Impact factor: 10.864

8.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

9.  Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

Authors:  T Poynard; P Bedossa; P Opolon
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

10.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

View more
  14 in total

Review 1.  Liver elastography, comments on EFSUMB elastography guidelines 2013.

Authors:  Xin-Wu Cui; Mireen Friedrich-Rust; Chiara De Molo; Andre Ignee; Dagmar Schreiber-Dietrich; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 2.  Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Authors:  Jeanne M Horowitz; Sudhakar K Venkatesh; Richard L Ehman; Kartik Jhaveri; Patrick Kamath; Michael A Ohliger; Anthony E Samir; Alvin C Silva; Bachir Taouli; Michael S Torbenson; Michael L Wells; Benjamin Yeh; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2017-08

3.  Point shear wave elastography method for assessing liver stiffness.

Authors:  Giovanna Ferraioli; Carmine Tinelli; Raffaella Lissandrin; Mabel Zicchetti; Barbara Dal Bello; Gaetano Filice; Carlo Filice
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

4.  Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis.

Authors:  Giovanna Ferraioli; Carmine Tinelli; Raffaella Lissandrin; Mabel Zicchetti; Barbara Dal Bello; Gaetano Filice; Carlo Filice
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

Review 5.  Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.

Authors:  Cristina Stasi; Stefano Milani
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 6.  Clinical Application of Transient Elastography in the Diagnosis of Liver Fibrosis: an Expert Panel Review and Opinion.

Authors: 
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

7.  The frequency and determinants of liver stiffness measurement failure: a retrospective study of "real-life" 38,464 examinations.

Authors:  Dong Ji; Qing Shao; Ping Han; Fan Li; Bing Li; Hong Zang; Xiaoxia Niu; Zhongbin Li; Shaojie Xin; Guofeng Chen
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

Review 8.  Transient elastography in clinical detection of liver cirrhosis: A systematic review and meta-analysis.

Authors:  Xiao-Xia Geng; Ren-Gang Huang; Jian-Mei Lin; Nan Jiang; Xing-Xiang Yang
Journal:  Saudi J Gastroenterol       Date:  2016 Jul-Aug       Impact factor: 2.485

9.  Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.

Authors:  Tarik Asselah; Christophe Moreno; Christoph Sarrazin; Michael Gschwantler; Graham R Foster; Antonio Craxí; Peter Buggisch; Faisal Sanai; Ceyhun Bicer; Oliver Lenz; Gino Van Dooren; Catherine Nalpas; Isabelle Lonjon-Domanec; Michael Schlag; Maria Buti
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

10.  Ultrasound shear wave elastography and liver fibrosis: A Prospective Multicenter Study.

Authors:  Joyce Anyona Sande; Suleman Verjee; Sudhir Vinayak; Farin Amersi; Munir Ghesani
Journal:  World J Hepatol       Date:  2017-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.